Balancing blood iron levels is the key to living longer
Phys.org - 16-Jul-2020Genes linked to iron metabolism were also responsible for age related diseases
Joris Deelen
Geneticist and Research Group leader at the Max Planck Institute for Biology of Ageing
Deelen studied biomedicine at Leiden University in the Netherlands from 2003 to 2014 and worked as a postdoctoral researcher at the Leiden University Medical Centre under Eline Slagboom. In 2016 he moved to the department of Institute Director Linda Partridge at the Max Planck Institute for Biology of Aging in Cologne. At the beginning of April 2020 he started his own research group "Genetics and Biomarkers of Human Ageing". He is particularly interested in elderly people and long-lived families in order to find out the genetic basis for a long life and to identify so-called biomarkers that can provide information on health in old age.
Visit website: https://www.age.mpg.de/science/research-laboratories/deelen
See also: 
Max Planck Institute for Biology of Ageing
- Scientific research institute dedicated to age research
Details last updated 27-Nov-2020
Joris Deelen is also referenced in the following:
ARDD 2022 - 9th Aging Research and Drug Discovery Meeting
29-Aug-2022 to 02-Sep-2022
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Longevity Investors Conference 2023
27-Sep-2023 to 29-Sep-2023
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger, Dr. Tobias Reichmuth and Daniel Koetser
Longevity Summit Dublin 2024
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
Nutrition and the biology of ageing
12-Sep-2022 to 14-Sep-2022
Event about nutrition and its impact on metabolism organized by British Society for Research on Ageing
Rare Genetic Variants Support Human Superlongevity - Joris Deelen at Longevity Summit Dublin 2024
Joris Deelen delivered a keynote on how rare genetic variants support human superlongevity
Joris Deelen News
